Open AccessEffect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis
Author(s) -
Chin Kook Rhee,
Jung Won Park,
Heung-Woo Park,
You Sook Cho
Publication year - 2022
Publication title -
allergy, asthma and immunology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.356
H-Index - 45
eISSN - 2092-7363
pISSN - 2092-7355
DOI - 10.4168/aair.2022.14.2.182
Subject(s) - dupilumab , medicine , exacerbation , asthma , placebo , adverse effect , bronchodilator , quality of life (healthcare) , clinical endpoint , randomized controlled trial , incidence (geometry) , pathology , physics , alternative medicine , nursing , optics
To assess the effect of dupilumab on the annualized severe exacerbation rates, change in forced expiratory volume at first second (FEV1), overall asthma control and health-related quality of life in Korean patients from the LIBERTY ASTHMA QUEST study.